Literature DB >> 24794706

Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expression.

Chunxiao Xu1, Christine M Fillmore2, Shohei Koyama3, Hongbo Wu4, Yanqiu Zhao4, Zhao Chen1, Grit S Herter-Sprie1, Esra A Akbay1, Jeremy H Tchaicha1, Abigail Altabef1, Jacob B Reibel1, Zandra Walton5, Hongbin Ji6, Hideo Watanabe7, Pasi A Jänne1, Diego H Castrillon8, Anil K Rustgi9, Adam J Bass10, Gordon J Freeman11, Robert F Padera12, Glenn Dranoff3, Peter S Hammerman13, Carla F Kim14, Kwok-Kin Wong15.   

Abstract

Lung squamous cell carcinoma (SCC) is a deadly disease for which current treatments are inadequate. We demonstrate that biallelic inactivation of Lkb1 and Pten in the mouse lung leads to SCC that recapitulates the histology, gene expression, and microenvironment found in human disease. Lkb1;Pten null (LP) tumors expressed the squamous markers KRT5, p63 and SOX2, and transcriptionally resembled the basal subtype of human SCC. In contrast to mouse adenocarcinomas, the LP tumors contained immune populations enriched for tumor-associated neutrophils. SCA1(+)NGFR(+) fractions were enriched for tumor-propagating cells (TPCs) that could serially transplant the disease in orthotopic assays. TPCs in the LP model and NGFR(+) cells in human SCCs highly expressed Pd-ligand-1 (PD-L1), suggesting a mechanism of immune escape for TPCs.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24794706      PMCID: PMC4112370          DOI: 10.1016/j.ccr.2014.03.033

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  45 in total

1.  Identification of bronchioalveolar stem cells in normal lung and lung cancer.

Authors:  Carla F Bender Kim; Erica L Jackson; Amber E Woolfenden; Sharon Lawrence; Imran Babar; Sinae Vogel; Denise Crowley; Roderick T Bronson; Tyler Jacks
Journal:  Cell       Date:  2005-06-17       Impact factor: 41.582

2.  Role of PTEN in basal cell derived lung carcinogenesis.

Authors:  Stephen P Malkoski; Timothy G Cleaver; Joshua J Thompson; Whitney P Sutton; Sarah M Haeger; Karen J Rodriguez; Shi-Long Lu; Daniel Merrick; Xiao-Jing Wang
Journal:  Mol Carcinog       Date:  2013-04-26       Impact factor: 4.784

3.  Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations.

Authors:  Natasha Rekhtman; Paul K Paik; Maria E Arcila; Laura J Tafe; Geoffrey R Oxnard; Andre L Moreira; William D Travis; Maureen F Zakowski; Mark G Kris; Marc Ladanyi
Journal:  Clin Cancer Res       Date:  2012-01-06       Impact factor: 12.531

4.  Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

Authors:  Suzanne L Topalian; F Stephen Hodi; Julie R Brahmer; Scott N Gettinger; David C Smith; David F McDermott; John D Powderly; Richard D Carvajal; Jeffrey A Sosman; Michael B Atkins; Philip D Leming; David R Spigel; Scott J Antonia; Leora Horn; Charles G Drake; Drew M Pardoll; Lieping Chen; William H Sharfman; Robert A Anders; Janis M Taube; Tracee L McMiller; Haiying Xu; Alan J Korman; Maria Jure-Kunkel; Shruti Agrawal; Daniel McDonald; Georgia D Kollia; Ashok Gupta; Jon M Wigginton; Mario Sznol
Journal:  N Engl J Med       Date:  2012-06-02       Impact factor: 91.245

5.  Evidence that SOX2 overexpression is oncogenic in the lung.

Authors:  Yun Lu; Christopher Futtner; Jason R Rock; Xia Xu; Walter Whitworth; Brigid L M Hogan; Mark W Onaitis
Journal:  PLoS One       Date:  2010-06-10       Impact factor: 3.240

Review 6.  Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression.

Authors:  Claudia A Dumitru; Stephan Lang; Sven Brandau
Journal:  Semin Cancer Biol       Date:  2013-02-26       Impact factor: 15.707

7.  Sox2 cooperates with inflammation-mediated Stat3 activation in the malignant transformation of foregut basal progenitor cells.

Authors:  Kuancan Liu; Ming Jiang; Yun Lu; Hao Chen; Jun Sun; Shaoping Wu; Wei-Yao Ku; Hiroshi Nakagawa; Yoshiaki Kita; Shoji Natsugoe; Jeffrey H Peters; Anil Rustgi; Mark W Onaitis; Amy Kiernan; Xiaoxin Chen; Jianwen Que
Journal:  Cell Stem Cell       Date:  2013-03-07       Impact factor: 24.633

8.  Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/snail signaling pathway.

Authors:  Y-L Hsu; M-F Hou; P-L Kuo; Y-F Huang; E-M Tsai
Journal:  Oncogene       Date:  2012-10-08       Impact factor: 9.867

9.  GSEA-P: a desktop application for Gene Set Enrichment Analysis.

Authors:  Aravind Subramanian; Heidi Kuehn; Joshua Gould; Pablo Tamayo; Jill P Mesirov
Journal:  Bioinformatics       Date:  2007-07-20       Impact factor: 6.937

10.  Self-renewal and chemotherapy resistance of p75NTR positive cells in esophageal squamous cell carcinomas.

Authors:  Sheng-Dong Huang; Yang Yuan; Xiao-Hong Liu; De-Jun Gong; Chen-Guang Bai; Feng Wang; Jun-Hui Luo; Zhi-Yun Xu
Journal:  BMC Cancer       Date:  2009-01-10       Impact factor: 4.430

View more
  171 in total

Review 1.  The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome.

Authors:  Romain Remark; Christian Becker; Jorge E Gomez; Diane Damotte; Marie-Caroline Dieu-Nosjean; Catherine Sautès-Fridman; Wolf-Herman Fridman; Charles A Powell; Nasser K Altorki; Miriam Merad; Sacha Gnjatic
Journal:  Am J Respir Crit Care Med       Date:  2015-02-15       Impact factor: 21.405

2.  Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts.

Authors:  Babak Behnam Azad; Ala Lisok; Samit Chatterjee; John T Poirier; Mrudula Pullambhatla; Gary D Luker; Martin G Pomper; Sridhar Nimmagadda
Journal:  J Nucl Med       Date:  2016-02-23       Impact factor: 10.057

3.  LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-small Cell Lung Cancer Plasticity and Therapeutic Response.

Authors:  Fuming Li; Xiangkun Han; Fei Li; Rui Wang; Hui Wang; Yijun Gao; Xujun Wang; Zhaoyuan Fang; Wenjing Zhang; Shun Yao; Xinyuan Tong; Yuetong Wang; Yan Feng; Yihua Sun; Yuan Li; Kwok-Kin Wong; Qiwei Zhai; Haiquan Chen; Hongbin Ji
Journal:  Cancer Cell       Date:  2015-04-30       Impact factor: 31.743

Review 4.  Notch as a tumour suppressor.

Authors:  Craig S Nowell; Freddy Radtke
Journal:  Nat Rev Cancer       Date:  2017-02-03       Impact factor: 60.716

5.  Lung Cancer Subtypes Generate Unique Immune Responses.

Authors:  Stephanie E Busch; Mark L Hanke; Julia Kargl; Heather E Metz; David MacPherson; A McGarry Houghton
Journal:  J Immunol       Date:  2016-10-31       Impact factor: 5.422

6.  The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment.

Authors:  Gurkan Mollaoglu; Alex Jones; Sarah J Wait; Anandaroop Mukhopadhyay; Sangmin Jeong; Rahul Arya; Soledad A Camolotto; Timothy L Mosbruger; Chris J Stubben; Christopher J Conley; Arjun Bhutkar; Jeffery M Vahrenkamp; Kristofer C Berrett; Melissa H Cessna; Thomas E Lane; Benjamin L Witt; Mohamed E Salama; Jason Gertz; Kevin B Jones; Eric L Snyder; Trudy G Oliver
Journal:  Immunity       Date:  2018-10-16       Impact factor: 31.745

Review 7.  Deciphering the cells of origin of squamous cell carcinomas.

Authors:  Adriana Sánchez-Danés; Cédric Blanpain
Journal:  Nat Rev Cancer       Date:  2018-09       Impact factor: 60.716

8.  Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance.

Authors:  Youngtae Jeong; Ngoc T Hoang; Alexander Lovejoy; Henning Stehr; Aaron M Newman; Andrew J Gentles; William Kong; Diana Truong; Shanique Martin; Aadel Chaudhuri; Diane Heiser; Li Zhou; Carmen Say; Justin N Carter; Susan M Hiniker; Billy W Loo; Robert B West; Philip Beachy; Ash A Alizadeh; Maximilian Diehn
Journal:  Cancer Discov       Date:  2016-09-23       Impact factor: 39.397

Review 9.  Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy.

Authors:  Jinfang Zhang; Fabin Dang; Junming Ren; Wenyi Wei
Journal:  Trends Biochem Sci       Date:  2018-10-01       Impact factor: 13.807

Review 10.  Predictive biomarkers of response to PD-1/PD-L1 immune checkpoint inhibitors in non-small cell lung cancer.

Authors:  Kazuhiko Shien; Vassiliki A Papadimitrakopoulou; Ignacio I Wistuba
Journal:  Lung Cancer       Date:  2016-06-21       Impact factor: 5.705

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.